BIOMAT Database Logo BIOMAT Database Logo

[Studies on beta-lactam antibiotics for medicinal purpose. XVIII. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3- substitut ed methyl-3-cephem-4-carboxylic acid derivatives]. 1986

H Sadaki, and H Imaizumi, and T Inaba, and T Hirakawa, and Y Murotani, and Y Watanabe, and S Minami, and I Saikawa

UI MeSH Term Description Entries
D008297 Male Males
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

H Sadaki, and H Imaizumi, and T Inaba, and T Hirakawa, and Y Murotani, and Y Watanabe, and S Minami, and I Saikawa
[Studies on FK482. II. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-substituted acetamido]-3-vinyl-3-cephem-4-carboxylic acid derivatives].
April 1990, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Sadaki, and H Imaizumi, and T Inaba, and T Hirakawa, and Y Murotani, and Y Watanabe, and S Minami, and I Saikawa
[Studies on beta-lactam antibiotics for medicinal purposes. XXII. Studies on the metabolism of pivaloyloxymethyl (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-3-cephem-4-carboxylate (T-2588) (2)].
June 1986, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Sadaki, and H Imaizumi, and T Inaba, and T Hirakawa, and Y Murotani, and Y Watanabe, and S Minami, and I Saikawa
Synthesis and structure-activity relationships of 7 beta-[2-(2-aminothiazol-4-yl)acetamido]cephalosporin derivatives. VI. Alternative syntheses of 7 beta-[2-(2-aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]cephalosporin derivatives.
February 1981, The Journal of antibiotics,
H Sadaki, and H Imaizumi, and T Inaba, and T Hirakawa, and Y Murotani, and Y Watanabe, and S Minami, and I Saikawa
Studies on prodrugs of cephalosporins. I. Synthesis and biological properties of glycyloxybenzoyloxymethyl and glycylaminobenzoyloxymethyl esters of 7 beta-[2-(2- aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3- methyl-3-cephem-4-carboxylic acid.
February 1984, Chemical & pharmaceutical bulletin,
H Sadaki, and H Imaizumi, and T Inaba, and T Hirakawa, and Y Murotani, and Y Watanabe, and S Minami, and I Saikawa
Studies on beta-lactam antibiotics VIII. Structure-activity relationships of 7 beta-[(Z)-2-carboxymethoxyimino-2-arylacetamido]-3-cephem- 4-carboxylic acids.
August 1985, The Journal of antibiotics,
H Sadaki, and H Imaizumi, and T Inaba, and T Hirakawa, and Y Murotani, and Y Watanabe, and S Minami, and I Saikawa
Studies on beta-lactam antibiotics. IV. Structure-activity relationships of 7 beta-[(Z)-2-alkoxyimino-2-(2-amino-4-thiazolyl)acetamido]-3-cephem-4-carboxylic acids.
October 1981, The Journal of antibiotics,
H Sadaki, and H Imaizumi, and T Inaba, and T Hirakawa, and Y Murotani, and Y Watanabe, and S Minami, and I Saikawa
Orally active cephalosporins. III. Synthesis and structure-activity relationships of new 3-heterocyclicthiomethylthio-7 beta-[(Z)- 2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-cephem-4 -carboxylic acids.
February 1993, The Journal of antibiotics,
H Sadaki, and H Imaizumi, and T Inaba, and T Hirakawa, and Y Murotani, and Y Watanabe, and S Minami, and I Saikawa
[Studies on FK482 (Cefdinir). III. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-aryl-2-hydroxyiminoacetamido]-3-vinyl-3- cephem-4-carboxylic acid derivatives].
September 1990, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Sadaki, and H Imaizumi, and T Inaba, and T Hirakawa, and Y Murotani, and Y Watanabe, and S Minami, and I Saikawa
Synthesis and structure-activity relationships of 7 beta-[2-(2-aminothiazol-4-yl)acetamido]cephalosporin derivatives. V. Synthesis and antibacterial activity of 7 beta-[2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-cephalosporin derivates and related compounds.
February 1981, The Journal of antibiotics,
H Sadaki, and H Imaizumi, and T Inaba, and T Hirakawa, and Y Murotani, and Y Watanabe, and S Minami, and I Saikawa
Synthesis and oral activity of pivaloyloxymethyl 7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3(Z)- (4-methylthiazol-5-yl)vinyl-3-cephem-4-carboxylate (ME1207) and its related compound.
September 1991, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!